Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 22.50p on 23-06-2025 at 06:30:02
Change 0.00p 0%
Buy 25.00p
Sell 20.00p
Buy / Sell CRTX Shares
Last Trade: Sell 500.00 at 22.00p
Day's Volume: 0
Last Close: 23.50p
Open: 0.00p
ISIN: VGG042401262
Day's Range 0.00p - 0.00p
52wk Range: 5.25p - 29.00p
Market Capitalisation: £8m
VWAP: 0.00p
Shares in Issue: 33m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 500 22.00p Ordinary
15:45:07 - 20-Jun-25
Sell* 928 22.00p Ordinary
14:44:27 - 20-Jun-25
Sell* 9,048 23.40p Ordinary
12:25:34 - 20-Jun-25
Unknown* 2,127 23.50p Ordinary
12:45:55 - 19-Jun-25
Sell* 626 22.00p Ordinary
12:29:28 - 19-Jun-25
Sell* 375 22.00p Ordinary
12:21:20 - 19-Jun-25
Sell* 1,265 23.40p Ordinary
11:22:08 - 19-Jun-25
Sell* 21,013 22.00p Ordinary
10:35:51 - 19-Jun-25
Buy* 102 25.00p Ordinary
09:48:13 - 19-Jun-25
Sell* 162 23.40p Ordinary
08:02:48 - 19-Jun-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Jun 2025 (Fri) 23.50 23.50 23.50 23.50 10,476
19th Jun 2025 (Thu) 23.50 23.50 23.50 23.50 25,670
18th Jun 2025 (Wed) 23.50 23.50 23.50 23.50 3,580
17th Jun 2025 (Tue) 23.50 23.50 23.50 23.50 11,239
16th Jun 2025 (Mon) 24.00 24.00 23.50 23.50 120,263
13th Jun 2025 (Fri) 23.00 24.00 23.00 24.00 199,921
12th Jun 2025 (Thu) 22.50 23.00 22.50 23.00 19,638
11th Jun 2025 (Wed) 20.50 22.50 20.50 22.50 184,339
10th Jun 2025 (Tue) 20.50 20.50 20.50 20.50 11,188
9th Jun 2025 (Mon) 20.00 20.50 20.00 20.50 18,742
6th Jun 2025 (Fri) 19.00 19.50 19.00 19.50 53,321
5th Jun 2025 (Thu) 19.00 19.00 19.00 19.00 3,263
4th Jun 2025 (Wed) 19.00 19.00 19.00 19.00 24,597
3rd Jun 2025 (Tue) 19.00 19.00 19.00 19.00 3,143
2nd Jun 2025 (Mon) 18.50 19.00 18.50 19.00 32,678
30th May 2025 (Fri) 18.50 18.50 18.50 18.50 25
29th May 2025 (Thu) 18.50 18.50 18.50 18.50 5,649
28th May 2025 (Wed) 18.50 18.50 18.50 18.50 1,006
27th May 2025 (Tue) 18.50 18.50 18.50 18.50 2,203
26th May 2025 (Mon) 17.00 17.00 17.00 17.00 0
23rd May 2025 (Fri) 18.50 18.50 18.50 18.50 1,050
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
13th Jun 2025 7:00 am RNS Final Results for the year ended 31 December 2024
9th Jun 2025 7:00 am RNS-R Best Paper Award
3rd Jun 2025 7:00 am RNS Establishment of Scientific Advisory Board
7th Apr 2025 11:46 am RNS Director Dealing
31st Mar 2025 7:00 am RNS Clinical Trial Update
27th Mar 2025 7:00 am RNS Innovate UK Grant Award
20th Dec 2024 7:00 am RNS Appointment of Specialist Clinical CRO
18th Dec 2024 7:00 am RNS European Patent Grant
19th Sep 2024 7:00 am RNS Interim Results
9th Sep 2024 7:00 am RNS Notice of Interim Results & IMC Presentation
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

CRISM Therapeutics hails progress in glioblastoma as loss widens

13th Jun 2025 09:43

(Alliance News) - CRISM Therapeutics Corp on Friday said it is confident in its prospects, citing progress in glioblastoma, as it reported an increased loss. Read More

CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial

3rd Jun 2025 12:24

(Alliance News) - CRISM Therapeutics Corp on Tuesday said it has established a scientific advisory board as it prepares to submit a clinical trial application for its lead product, ChemoSeed. Read More

IN BRIEF: CRISM Therapeutics gets European patent for tumour therapy

19th Dec 2024 08:32

CRISM Therapeutics Corp - Surrey-headquartered pharmaceutical firm - Granted a European patent for its lead product ChemoSeed by the European Patent Office. This covers the manufacturing process for the preparation of chemotherapeutic drug implants and their use in therapy, particularly in treating brain tumours such as high grade glioma. ChemoSeed facilitates the local delivery of irinotecan directly to the brain tumour resection site, which allows the delivery of larger doses and reduces systemic concentrations. This alleviates traditional side effects for the patient. Read More

UK earnings, trading statements calendar - next 7 days

12th Sep 2024 13:55

Read More

IN BRIEF: Crism flags contract talks, reacts to share price surge

3rd Jul 2024 19:03

Crism Therapeutics Corp - Pharmaceutical company headquartered in Surrey - Notes the increase in the share price on Wednesday, confirms that it is not aware of any specific reason for the increase. Points out the share price has fallen since admission to AIM in May. Continues to work on its stated strategy of submitting a clinical trial application in the second half of 2024 for its lead product, ChemoSeed. Also at contract stage to provide services with an early stage UK small and medium sized enterprise who are seeking to utilise Crism's drug formulation expertise. The value of that contract would be around GBP230,000. Read More

See more Crism Thera news
FTSE 100 Latest
Value8,774.65
Change0.00

Login to your account

Forgot Password?

Not Registered